Cargando…

Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer

Anti-PD-1 therapy has shown promising outcomes in the treatment of different types of cancer. It is of fundamental interest to analyze the efficacy of anti-PD-1 therapy in cancer patients infected with hepatitis B virus (HBV) since the comorbidity of HBV and cancer is widely documented. We designed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jie, Chen, Guanming, Wang, Jiuling, Zhou, Bo, Sun, Xuemin, Wang, Jinsong, Tang, Shu, Xing, Xiangju, Hu, Xiaofei, Zhao, Yang, Peng, Yu, Shi, Wenjiong, Zhao, Tingting, Wu, Yuzhang, Zhong, Hanbing, Hong, Ni, Ruan, Zhihua, Zhang, Yi, Jin, Wenfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119302/ https://www.ncbi.nlm.nih.gov/pubmed/37080999 http://dx.doi.org/10.1038/s41389-023-00468-0

Ejemplares similares

Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma
por: Li, Debao, et al.
Publicado: (2023)

The clinical and immunological characteristics of COVID‐19 patients with delayed SARS‐CoV‐2 virus clearance
por: Wang, Jinsong, et al.
Publicado: (2023)

The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
por: Xu, Huan, et al.
Publicado: (2012)

Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
por: Chen, Ruiying, et al.
Publicado: (2022)

Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV
por: Lv, Yanbo, et al.
Publicado: (2009)

PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
por: Wu, Yanhua, et al.
Publicado: (2017)

Expression of CD39 on FoxP3(+ )T regulatory cells correlates with progression of HBV infection
por: Tang, Yan, et al.
Publicado: (2012)

Bismuth fire assay preconcentration and empirical coefficient LA-ICP-MS for the determination of ultra-trace Pt and Pd in geochemical samples
por: Ni, Wenshan, et al.
Publicado: (2022)

Efficacy of PD-1/PD-L1 Inhibitors versus Chemotherapy in Lung Cancer with Brain Metastases: A Systematic Review and Meta-Analysis
por: Yang, Xiaojun, et al.
Publicado: (2022)

Achievement of long-term local control after radiation and anti-PD-1 immunotherapy in locally advanced non-small cell lung cancer
por: Jing, Zhao, et al.
Publicado: (2021)

Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B
por: Hu, Gang, et al.
Publicado: (2021)

Is PD-1 blockade a potential therapy for HBV?
por: Féray, Cyrille, et al.
Publicado: (2019)

microRNA-4717 differentially interacts with its polymorphic target in the PD1 3′ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases
por: Zhang, Guoyu, et al.
Publicado: (2015)

HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection
por: Zaongo, Silvere D., et al.
Publicado: (2022)

Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
por: Zeng, Zhen, et al.
Publicado: (2011)

Depth Density Achieves a Better Result for Semantic Segmentation with the Kinect System
por: Deng, Hanbing, et al.
Publicado: (2020)

The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome
por: Fukuchi, Takahiko, et al.
Publicado: (2019)

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
por: Yeh, Chun-Nan, et al.
Publicado: (2018)

Different types of viral-host junction found in HBV integration breakpoints in HBV-infected patients
por: Ruan, Peng, et al.
Publicado: (2019)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma
por: Li, Zhu, et al.
Publicado: (2016)

Enrichment of Ly6C(hi) monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model
por: Zhao, Weidong, et al.
Publicado: (2017)

CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer
por: Li, Enhao, et al.
Publicado: (2021)

Type VII Aplasia Cutis Congenita in Neonates Related to Maternal HBV Infection? Case Report and Literature Review
por: Li, Guanming, et al.
Publicado: (2023)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
por: Zhang, Pei, et al.
Publicado: (2017)

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection
por: Ferrando-Martinez, Sara, et al.
Publicado: (2021)

PD-L1 Expression and CD8(+) T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer
por: Wang, Yangyang, et al.
Publicado: (2018)

Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma
por: Yang, Liu, et al.
Publicado: (2018)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
por: Schmidt, Lars Henning, et al.
Publicado: (2015)

The Authors' Reply to “The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome”
por: Kaito, Satoshi, et al.
Publicado: (2019)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021)

Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice()
por: Zhou, Lili, et al.
Publicado: (2007)

Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?
por: Zhang, Xiaoyun, et al.
Publicado: (2022)

Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS–CoV F(ab′)(2) in macaque()
por: Xu, Yunsheng, et al.
Publicado: (2007)

Closing the gap to achieve HBV elimination by 2030: A global pursuit fueled by regional successes
por: Wong, Robert J.
Publicado: (2021)

ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers
por: Chang, Bin, et al.
Publicado: (2009)

Single-cell analysis reveals HBV-specific PD-1(+)CD8(+) TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients
por: Liu, Lulu, et al.
Publicado: (2023)

Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection
por: Balsitis, Scott, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u2c56rapsaqpo8dkce4fnn7046